Nuclear Medicine
The mission of the section is to enhance capabilities of developing Member States to address important health needs by the use of nuclear medicine functional studies or molecular biology techniques.
In medical science these procedures have been recognized as indispensable tools for the diagnosis and treatment of a large number of benign and malignant disorders. They provide functional information on a cost-effective basis in comparison with other competitive technologies.
One of the fastest growing techniques is positron emission tomography (PET) and increasingly nuclear medicine is involved with therapeutic applications.
This sub-programme continues to contribute significantly to education and is committed to continuous quality improvement of health care in Member States. Our vision is to pursue uniformity and adherence of the professional practice of nuclear medicine to the highest standards achievable.
Positron emission tomography (PET)
FDG-F18 PET scan showing tracer
uptake in liver and lumbar spine. The picture on your left showing PET-CT
fusion image; the picture on your right showing FDG-F18 distribution
Nuclear medicine therapeutic applications- Liver cancer
Liver cancer treatment with Re188-Lipiodol; the right side image shows tumor size reduction following radiometabolic theraphy.